| 356 - BARMER - Mometason - R01AD09 | DAK-Gesundheit | BG ALIUD / STADAPHARM GbR, BG Hexal 1A Pharma GbR, BG TEVA ratiopharm GbR | — | 6 Aug 2026 |
| 351 - BARMER - Morphin - N02AA01 (Oral retardiert) | DAK-Gesundheit | BG ALIUD / STADAPHARM GbR, BG Heumann / G.L. Pharma GbR, BG TEVA ratiopharm GbR | — | 6 Aug 2026 |
| 341 - BARMER - Acetylsalicylsäure - B01AC06 | DAK-Gesundheit | BG ALIUD / STADAPHARM GbR, BG Hexal 1A Pharma GbR, BG TEVA ratiopharm GbR | — | 6 Aug 2026 |
| 338 - BARMER - Beclometason - R03BA01 | DAK-Gesundheit | BG TEVA ratiopharm GbR, Glenmark Arzneimittel GmbH | — | 6 Aug 2026 |
| 334 - BARMER - Morphin - N02AA01 (ILO) | DAK-Gesundheit | BG TEVA ratiopharm GbR, hameln pharma gmbh | — | 6 Aug 2026 |
| 328 - BARMER - Furosemid - C03CA01 | DAK-Gesundheit | BG Hexal 1A Pharma GbR, BG TEVA ratiopharm GbR | — | 6 Aug 2026 |
| 256 - TK / hkk / HEK - Mometason - R01AD09 | DAK-Gesundheit | BG ALIUD / STADAPHARM GbR, BG Hexal 1A Pharma GbR, BG TEVA ratiopharm GbR | — | 6 Aug 2026 |
| 251 - TK / hkk / HEK - Morphin - N02AA01 (Oral retardiert) | DAK-Gesundheit | BG ALIUD / STADAPHARM GbR, BG Heumann / G.L. Pharma GbR, BG TEVA ratiopharm GbR | — | 6 Aug 2026 |
| 249 - TK / hkk / HEK - Apremilast - L04AA32 | DAK-Gesundheit | 089Pharm GmbH, BG TEVA ratiopharm GbR, Glenmark Arzneimittel GmbH | — | 6 Aug 2026 |
| 241 - TK / hkk / HEK - Acetylsalicylsäure - B01AC06 | DAK-Gesundheit | BG ALIUD / STADAPHARM GbR, BG Hexal 1A Pharma GbR, BG TEVA ratiopharm GbR | — | 6 Aug 2026 |
| 238 - TK / hkk / HEK - Beclometason - R03BA01 | DAK-Gesundheit | BG TEVA ratiopharm GbR, Glenmark Arzneimittel GmbH | — | 6 Aug 2026 |
| 234 - TK / hkk / HEK - Morphin - N02AA01 (ILO) | DAK-Gesundheit | BG TEVA ratiopharm GbR, hameln pharma gmbh | — | 6 Aug 2026 |
| 228 - TK / hkk / HEK - Furosemid - C03CA01 | DAK-Gesundheit | BG Hexal 1A Pharma GbR, BG TEVA ratiopharm GbR | — | 6 Aug 2026 |
| 156 - DAK / KKH - Mometason - R01AD09 | DAK-Gesundheit | BG ALIUD / STADAPHARM GbR, BG Hexal 1A Pharma GbR, BG TEVA ratiopharm GbR | — | 6 Aug 2026 |
| 151 - DAK / KKH - Morphin - N02AA01 (Oral retardiert) | DAK-Gesundheit | BG ALIUD / STADAPHARM GbR, BG Heumann / G.L. Pharma GbR, BG TEVA ratiopharm GbR | — | 6 Aug 2026 |
| 149 - DAK / KKH - Apremilast - L04AA32 | DAK-Gesundheit | 089Pharm GmbH, BG TEVA ratiopharm GbR, Glenmark Arzneimittel GmbH | — | 6 Aug 2026 |
| 141 - DAK / KKH - Acetylsalicylsäure - B01AC06 | DAK-Gesundheit | BG Hexal 1A Pharma GbR, BG TEVA ratiopharm GbR, Dexcel Pharma GmbH | — | 6 Aug 2026 |
| 138 - DAK / KKH - Beclometason - R03BA01 | DAK-Gesundheit | BG TEVA ratiopharm GbR, Glenmark Arzneimittel GmbH | — | 6 Aug 2026 |
| 134 - DAK / KKH - Morphin - N02AA01 (ILO) | DAK-Gesundheit | BG TEVA ratiopharm GbR, hameln pharma gmbh | — | 6 Aug 2026 |
| 128 - DAK / KKH - Furosemid - C03CA01 | DAK-Gesundheit | BG Hexal 1A Pharma GbR, BG TEVA ratiopharm GbR | — | 6 Aug 2026 |
| 356 - BARMER - Mometason - R01AD09 | DAK-Gesundheit | BG ALIUD / STADAPHARM GbR, BG Hexal 1A Pharma GbR, BG TEVA ratiopharm GbR | — | 5 Aug 2026 |
| 351 - BARMER - Morphin - N02AA01 (Oral retardiert) | DAK-Gesundheit | BG ALIUD / STADAPHARM GbR, BG Heumann / G.L. Pharma GbR, BG TEVA ratiopharm GbR | — | 5 Aug 2026 |
| 341 - BARMER - Acetylsalicylsäure - B01AC06 | DAK-Gesundheit | BG ALIUD / STADAPHARM GbR, BG Hexal 1A Pharma GbR, BG TEVA ratiopharm GbR | — | 5 Aug 2026 |
| 338 - BARMER - Beclometason - R03BA01 | DAK-Gesundheit | BG TEVA ratiopharm GbR, Glenmark Arzneimittel GmbH | — | 5 Aug 2026 |
| 334 - BARMER - Morphin - N02AA01 (ILO) | DAK-Gesundheit | BG TEVA ratiopharm GbR, hameln pharma gmbh | — | 5 Aug 2026 |
| 328 - BARMER - Furosemid - C03CA01 | DAK-Gesundheit | BG Hexal 1A Pharma GbR, BG TEVA ratiopharm GbR | — | 5 Aug 2026 |
| 256 - TK / hkk / HEK - Mometason - R01AD09 | DAK-Gesundheit | BG ALIUD / STADAPHARM GbR, BG Hexal 1A Pharma GbR, BG TEVA ratiopharm GbR | — | 5 Aug 2026 |
| 251 - TK / hkk / HEK - Morphin - N02AA01 (Oral retardiert) | DAK-Gesundheit | BG ALIUD / STADAPHARM GbR, BG Heumann / G.L. Pharma GbR, BG TEVA ratiopharm GbR | — | 5 Aug 2026 |
| 249 - TK / hkk / HEK - Apremilast - L04AA32 | DAK-Gesundheit | 089Pharm GmbH, BG TEVA ratiopharm GbR, Glenmark Arzneimittel GmbH | — | 5 Aug 2026 |
| 241 - TK / hkk / HEK - Acetylsalicylsäure - B01AC06 | DAK-Gesundheit | BG ALIUD / STADAPHARM GbR, BG Hexal 1A Pharma GbR, BG TEVA ratiopharm GbR | — | 5 Aug 2026 |
| 238 - TK / hkk / HEK - Beclometason - R03BA01 | DAK-Gesundheit | BG TEVA ratiopharm GbR, Glenmark Arzneimittel GmbH | — | 5 Aug 2026 |
| 234 - TK / hkk / HEK - Morphin - N02AA01 (ILO) | DAK-Gesundheit | BG TEVA ratiopharm GbR, hameln pharma gmbh | — | 5 Aug 2026 |
| 228 - TK / hkk / HEK - Furosemid - C03CA01 | DAK-Gesundheit | BG Hexal 1A Pharma GbR, BG TEVA ratiopharm GbR | — | 5 Aug 2026 |
| 156 - DAK / KKH - Mometason - R01AD09 | DAK-Gesundheit | BG ALIUD / STADAPHARM GbR, BG Hexal 1A Pharma GbR, BG TEVA ratiopharm GbR | — | 5 Aug 2026 |
| 151 - DAK / KKH - Morphin - N02AA01 (Oral retardiert) | DAK-Gesundheit | BG ALIUD / STADAPHARM GbR, BG Heumann / G.L. Pharma GbR, BG TEVA ratiopharm GbR | — | 5 Aug 2026 |
| 149 - DAK / KKH - Apremilast - L04AA32 | DAK-Gesundheit | 089Pharm GmbH, BG TEVA ratiopharm GbR, Glenmark Arzneimittel GmbH | — | 5 Aug 2026 |
| 141 - DAK / KKH - Acetylsalicylsäure - B01AC06 | DAK-Gesundheit | BG Hexal 1A Pharma GbR, BG TEVA ratiopharm GbR, Dexcel Pharma GmbH | — | 5 Aug 2026 |
| 138 - DAK / KKH - Beclometason - R03BA01 | DAK-Gesundheit | BG TEVA ratiopharm GbR, Glenmark Arzneimittel GmbH | — | 5 Aug 2026 |
| 134 - DAK / KKH - Morphin - N02AA01 (ILO) | DAK-Gesundheit | BG TEVA ratiopharm GbR, hameln pharma gmbh | — | 5 Aug 2026 |
| 128 - DAK / KKH - Furosemid - C03CA01 | DAK-Gesundheit | BG Hexal 1A Pharma GbR, BG TEVA ratiopharm GbR | — | 5 Aug 2026 |
| Fusidinsäure (Welt) | BARMER Beschaffung und Vergabe | BG TEVA ratiopharm GbR, LEO Pharma GmbH | — | 1 Jul 2026 |
| Azithromycin (EU) | BARMER Beschaffung und Vergabe | BG TEVA ratiopharm GbR | — | 1 Jul 2026 |
| TK/HEK/hkk Wirkstoff Ticlopidin ATC WHO: B01AC05 | Kaufmännische Krankenkasse - KKH | BG TEVA ratiopharm GbR | — | 18 May 2026 |
| TK/HEK/hkk Wirkstoff Tenofovirdisoproxil und Emtricitabin ATC WHO: J05AR03 | Kaufmännische Krankenkasse - KKH | BG Heumann / Heunet GbR, BG TEVA ratiopharm GbR, PUREN Pharma GmbH & Co. KG | — | 18 May 2026 |
| TK/HEK/hkk Wirkstoff Tenofovirdisoproxil ATC WHO: J05AF07 | Kaufmännische Krankenkasse - KKH | BG Heumann / Heunet GbR, BG TEVA ratiopharm GbR, PUREN Pharma GmbH & Co. KG | — | 18 May 2026 |
| TK/HEK/hkk Wirkstoff Nilotinib ATC WHO: L01EA03 | Kaufmännische Krankenkasse - KKH | BG Heumann / Heunet GbR, BG TEVA ratiopharm GbR | — | 18 May 2026 |
| TK/HEK/hkk Wirkstoff Melperon ATC WHO: N05AD03 | Kaufmännische Krankenkasse - KKH | BG TEVA ratiopharm GbR, neuraxpharm Arzneimittel GmbH | — | 18 May 2026 |
| TK/HEK/hkk Wirkstoff Latanoprost ATC WHO: S01EE01 | Kaufmännische Krankenkasse - KKH | axunio Pharma GmbH, BG TEVA ratiopharm GbR, OmniVision GmbH | — | 18 May 2026 |
| TK/HEK/hkk Wirkstoff Imatinib ATC WHO: L01EA01 | Kaufmännische Krankenkasse - KKH | Accord Healthcare S.L.U. vertreten durch Accord Healthcare GmbH, BG ALIUD / STADAPHARM GbR, BG TEVA ratiopharm GbR | — | 18 May 2026 |
| TK/HEK/hkk Wirkstoff Haloperidol ATC WHO: N05AD01 | Kaufmännische Krankenkasse - KKH | BG TEVA ratiopharm GbR | — | 18 May 2026 |